Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuvectin vs Methotrexate in Head and Neck Cancer
NCT00006033Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Jun 2000
- Modality
- Gene Editing, Prophylactic Vaccines, Gene Silencing
- Countries
- 1
01
Overview
A Phase 2 trial of Leuvectin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Moffitt Cancer Center. Started Jun 2000; status: completed.
02
Drugs
Leuvectin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00006033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006033.